Refining processes for the co-development of genome-based therapeutics and companion diagnostic tests workshop summary
"Many drug developers have examined new strategies for creating efficiencies in their development processes, including the adoption of genomics-based approaches. Genomic data can identify new drug targets for both common and rare diseases, can predict which patients are likely to respond to a s...
Autores Corporativos: | , |
---|---|
Otros Autores: | |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Washington, District of Columbia :
National Academies Press
2014.
|
Edición: | 1st ed |
Materias: | |
Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622036906719 |
Tabla de Contenidos:
- ""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Abbreviations and Acronyms""; ""1 Introduction""; ""2 Regulatory Perspectives""; ""3 Perspectives from Patients, Providers, and Laboratory Representatives""; ""4 Perspectives of Diagnostic Test and Pharmaceutical Developers""; ""5 Perspectives of Payers and Regulators""; ""6 Concluding Observations""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographical Sketches""; ""Appendix C: Statement of Task""; ""Appendix D: Registered Attendees""